Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 4:06 pm Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% |
-1,519,596 (-30.57%) |
Filing History |
| 2024-02-09 4:09 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,342,083 9.100% |
15,966 (+0.22%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
3,788,682 6.200% |
1,195,158 (+46.08%) |
Filing History |
| 2024-01-19 4:38 pm Purchase |
2024-01-11 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 4,500,000 5.550% |
2,500,000 (+125.00%) |
Filing History |
| 2024-01-19 09:08 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-684,200 (-25.49%) |
Filing History |
| 2023-02-14 4:29 pm Unchanged |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,326,117 14.100% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:53 pm Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,150,000 4.100% |
-804,392 (-27.23%) |
Filing History |
| 2023-02-14 08:32 am Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,684,200 5.150% |
-132,750 (-4.71%) |
Filing History |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,981,324 5.700% |
116,524 (+4.07%) |
Filing History |
| 2023-02-10 4:31 pm Sale |
2022-08-15 | 13D | Dyne Therapeutics, Inc. DYN |
Vida Ventures II, LLC | 2,220,034 4.300% |
-740,012 (-25.00%) |
Filing History |
| 2023-02-09 4:04 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 4,970,899 9.500% |
19,596 (+0.40%) |
Filing History |
| 2023-02-09 11:01 am Sale |
2023-01-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,593,524 4.900% |
-25,094 (-0.96%) |
Filing History |
| 2023-02-08 2:57 pm Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
2,618,618 5.000% |
2,618,618 (New Position) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 0 0.000% |
-2,805,045 (Position Closed) |
Filing History |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 2,805,045 5.400% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,954,392 5.700% |
-940,000 (-24.14%) |
Filing History |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,864,800 5.600% |
-299,601 (-9.47%) |
Filing History |
| 2022-02-11 5:04 pm Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,326,117 14.200% |
-814,013 (-10.00%) |
Filing History |
| 2022-02-04 09:17 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Wellington Management Group LLP | 1,763,053 3.420% |
-1,141,669 (-39.30%) |
Filing History |
| 2022-01-20 4:27 pm Purchase |
2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,816,950 5.470% |
2,816,950 (New Position) |
Filing History |